ZF Fiedrichshoffen, Bachem Peptides, Jordan Industries,
Pharmakinetics, Wincor/Nixdorf, Wyeth, and many others.
PWA attracted the following companies regarding biomaterials and R&D collaborations with academic medicine:
AbbVie, ABL-Lyon Immunobiology, Amgen (Decode owner), Bayer, Biocartis, BioreclamationIVT, Bristle-Myers Squibb, Capital Biosciences, Celgene, CHTN, Conversant Bio, Desktopgenetics, Draper, Eli Lilly, Evotec, Exosome Diagnostics, Gilead, Greiner-Bio One North America, Human Metabolome Technologies America, Life Arc, Illumina, Incyte, Inspyr Therapeutics, Intellus, InVentive Health, Janssen/J&J, LAB Diagnostics, Lonza, LVL Technologies, Macrogen, Medtronic, Merck & Company, Milagen, Millipore Sigma, Natera, Nilogen Onco Systems, Novartis Institute for Biomedical Research, Pfizer, Precision for Medicine, ProLung, Qiagen, Quest Diagnostics, Taiho Oncology, Tocagen, Waters and Zen-Bio
R&D Project Sourcing
PWA has extensive experience in identification of funding opportunities in the US for University faculty groups and corporations. Our corporate offices are conveniently located near the US National Institutes of Health, HHS, FDA and the National Science Foundation.We maintain an exclusive database of private foundations and associations across the US that provide monies for research on specific diseases and other health matters.We identify project opportunities, give briefings to client principal investigators on important deliverable dates, including Letters of Intent, which we help prepare along with funding applications, and monitor the application process.
US Market Entry
PWA has assisted numerous European SME life science product and service companies with their strategic marketing plans for the US. Services included: review of business plans, editing of websites, competitor profiling, identification of technology and sales partners, licensees and attorneys for FDA filings, and preparation of marketing materials including power-point presentations and proposal writing. For a number of companies, PWA screened potential customers and arranged sales meetings in the US. A number or all of these services were provided to 4 Pharma Ltd. (data management/warehousing, statistics, IT, medical services), AB Aircontainer A.C. (refrigerated air cargo containers - biopharmaceuticals / vaccines), AirContainer Package System Sweden AB, Bioretec Ltd. (bioabsorbable surgical fixation devices for orthopaedics), Hermo Pharma Ltd. (now Herantis Pharma) (products targeting Parkinson’s Alzheimer’s and Amblyopia), Histola Research Ltd. (histology of hard and soft tissues, cryotechniques), Mobidiag Ltd. (molecular device technology to screen infectious diseases), NEXT Biomed Ltd. (developed recombinant binder proteins BHAP for HIV), and Novamass Ltd. (drug metabolism and other ADME studies).
Asset Characterization Studies
Awarded contract financed by the US Department of State through the International Science and Technology Center (ISTC) (www.istc.ru) in Moscow, Russia to evaluate and compile detailed profiles of 13 former Bioweapons research institutes in Russia. This evaluation involves assessment of intellectual property, identification of research expertise for drug discovery and development, administrative structure and opportunities for collaboration with private industry unique to each institute in order to help the institutes become self-sustaining. Conducted asset characterization study of pre-eminent faculty groups at Helsinki University (HU) and the Helsinki University of Technology (HUT), among other academic centers with life science programs directed toward the drug discovery needs of the pharmaceutical industry.
Evaluated American universities on behalf of the Finnish government to select a partner with the Helsinki University of Technology (HUT); facilitated the signing of a collaborative agreement between HUT and the University of Maryland to develop an MS Degree program for IT distance learning
Advised the Western Australia Legislative Committee on U.S. state government assistance programs to attract industry
Advised the U.S. National Association of Industrial and Office Properties on opportunities for investors and developers in Germany, Eastern Europe and Russia
Provided site selection services and identified investors for Burger King in eastern Germany
Consulted with the German Ministry of Tourism in Frankfurt on the international marketing of German health resorts
Identified qualified investors for an arena/sports complex for Siemens Real Estate in Berlin, Germany
Strategic Investment Location Studies
On behalf of the U.S. Department of Commerce (BISNIS) (www.bisnis.doc.gov), PWA assisted with organization of a "tripartite" initiative involving use of Finnish distributors/warehousers Tamro, Onninen and Kukomarkkinat to help US exporters sell goods to Russia, maximizing the advantages of the common border shared by Russia and Finland.
On behalf of the International Foundation of Technology and Investment (IFTI), Moscow, Russia, PWA conducted international market study identifying potential clients among the corporate, academic, donor agencies and other non-governmental sectors.
PWA acted as strategic business development advisor for the Center for Biotechnology and Gene Technology at Tallinn Technical University, Talinn, Estonia (www.ttu.ee/biogen), evaluating funding resources to expand the Center into a new science park and incubator for start-up companies, introducing potential partners for the design of facilities and park infrastructure and consulting on joint venture opportunities between the U.S. and Scandinavia.
PWA Identified strategic resources for biotechnology instrumentation companies in the Jena region of Thuringia, Germany for the BioRegio competition, resulting in an award to the region by the Federal Government from among 16 German States.
On behalf of Finn-Medi of Tampere, Finland, PWA completed asset characterization of its academic medicine programs and resources, specifically tissue engineering, cell technologies and biomaterials.
PWA developed strategic recruitment plan for Sago Science Park near Potsdam, Germany, maximizing the value to potential investors of the anchor tenant, the Federal Biological Research Center for Forestry and Agriculture.
PWA conducted a study for the Regional Municipality of Hamilton-Wentworth, Ontario, Canada to assess the feasibility of establishing a life science park in that location.
On behalf of the Soviet Ministry of Health, PWA developed marketing plan to attract international companies to locate facilities in Russia.
PWA advised the German state of Lower Saxony on development of Medical Park Hanover.
PWA conducted asset characterization study for Sweden's Uppsala University, Department of Immunology, Genetics and Pathology.
Organization of Business Investment Missions and Seminars
Pre-qualified / arranged investment meetings with U.S. Food Processing companies for executives from Brandenburg, Germany
Targeted U.S. biotechnology companies and arranged investment meetings for Helsinki University, Institute of Biotechnology
Organized and conducted benchmarking tour of the United States for the Regional Planning Council of Finland
Pre-qualified / arranged investment meetings with U.S. based Call Center companies for executives from Berlin Germany
Initiated Biotechnology Innovation Organization’s (USA) first European Partnering Event for 32 company members at Biotechnica Congress
Organized International Insurance Council (USA) seminar program in Germany
Assisted with organization and recruitment for Estonian Genome Project seminar in Tartu, Estonia
Assisted in organization of seminar in Berlin, Germany for AdvaMed (formerly Health Industry Manufacturing Association)